Global Health to meet investors in Noida and London in June
Global Health Limited has announced a schedule of meetings with analysts and institutional investors in Noida and London on June 17 and June 18, 2026. The sessions, organized by JP Morgan and IIFL Capital, will cover business performance and strategy without disclosing unpublished price sensitive information.

*this image is generated using AI for illustrative purposes only.
Global Health Limited has scheduled meetings with analysts and institutional investors in Noida and London for June 17 and June 18, 2026. The management will engage with investors during sessions organized by JP Morgan and IIFL Capital. The company confirmed that no unpublished price sensitive information will be disclosed during these interactions.
The meetings are part of the company's routine investor engagement activities. The schedule includes one group meeting and one one-on-one meeting, providing an opportunity for the management to discuss business performance and strategy with market participants.
The details of the scheduled meetings are as follows:
| Name | Date of Meeting | Type of Meeting | Place of Meeting | Mode of Meeting |
|---|---|---|---|---|
| JP Morgan | June 17, 2026 | Group Meeting | Noida | In Person |
| IIFL Capital | June 18, 2026 | One to One | London | In Person |
Global Health noted that the schedule is subject to change in case of unforeseen circumstances involving analysts, investors, or the company. The intimation was submitted to the exchanges pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Historical Stock Returns for Global Health
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -1.46% | -0.67% | +5.24% | +5.37% | +8.50% | +214.23% |
What strategic priorities is Global Health likely to emphasize during these investor meetings?
How might these engagements influence investor sentiment ahead of the company's next earnings report?
Could the discussions with JP Morgan and IIFL Capital signal potential partnerships or capital raising plans?






























